“…An indirect action involving thirdparty signaling molecules, like endocannabinoids, dopamine, adenosine (Chergui et al, 2000), or glutamate, is unlikely in view of the results obtained with the mixture of antagonists for various receptors including GABA-B, CB 1 , A 1 , D 4 , mGluRs, NMDA, nicotinic and ␣-2 adrenergic receptors. A direct action of KARs on transmitter release involving a G-protein-coupled signaling pathway has already been reported in other structures (Rodríguez-Moreno and Lerma, 1998;Cunha et al, 2000;Frerking et al, 2001;Lauri et al, 2005Lauri et al, , 2006Negrete-Diaz et al, 2006;Jin and Smith, 2007). This seems to be also the case in our recordings as indicated by the abolition of the KAR-mediated inhibitory effect in the presence of the PLC inhibitor, U73122.…”